AN2 Therapeutics, Inc. (ANTX) vs MediWound Ltd. (MDWD)
A side-by-side comparison of AN2 Therapeutics, Inc. and MediWound Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANTX
AN2 Therapeutics, Inc.
$5.34HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT
MDWD
MediWound Ltd.
$13.45HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Total return — ANTX vs MDWD
growth of $100 · dividends reinvested · last 5yANTX -63.6% (-18.3%/yr)MDWD -0.5% (-0.1%/yr)MDWD compounded faster over this window
ANTX MDWD
ANTX vs MDWD: by the numbers
- •ANTX is the larger company ($192M vs $173M market cap).
- •Both run net losses; ANTX's is the smaller (0.00% vs -170.10% net margin).
Metrics side by side
Valuation
| Metric | ANTX | MDWD |
|---|---|---|
| P/S ratio | N/A | 14.56 |
| P/B ratio | 2.53 | 4.85 |
Profitability
| Metric | ANTX | MDWD |
|---|---|---|
| Gross margin | 0.00% | 15.46% |
| Operating margin | 0.00% | -149.06% |
| Net margin | 0.00% | -170.10% |
| ROE | -47.78% | -56.61% |
| ROIC | -51.01% | -58.55% |
Growth (annualized)
| Metric | ANTX | MDWD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -13.99% |
| Total return CAGR (5Y) | N/A | -9.04% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.